Literature DB >> 19661531

Clinical aspects and comorbidities of psoriasis.

Fabio Ayala1, Fabrizio Ayala.   

Abstract

Psoriasis is a disease mediated by Th1 and Th17 cytokines that has different phenotypes (plaque, guttate, pustular, and erythrodermic type). Aside from the well known psoriatic arthritis, associated disorders may occur more frequently than expected, including Crohn's disease, anxiety/depression, and metabolic syndrome. This is based on a constellation of different factors, including abdominal obesity, atherogenic dyslipidemia, hypertension, and glucose intolerance, and is a strong predictor of type 2 diabetes, cardiovascular disease, and stroke. People with moderate to severe psoriasis have more risk for cardiac disease, presumably due to the inflammatory nature of psoriasis, causing inflammatory changes in coronary arteries. The strong association between psoriasis and obesity potentially makes psoriasis an important healthcare issue. Since cardiovascular risk factors are higher in psoriatic patients, dermatologists treating moderate to severe psoriasis should screen for their presence, thus approaching psoriasis as a potential multisystem disorder.

Entities:  

Mesh:

Year:  2009        PMID: 19661531     DOI: 10.3899/jrheum.090214

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  3 in total

1.  Addressing comorbidities in psoriatic disease.

Authors:  Priya Patel; Cheryl F Rosen; Vinod Chandran; Yang Justine Ye; Dafna D Gladman
Journal:  Rheumatol Int       Date:  2017-11-28       Impact factor: 2.631

2.  Which Psoriasis Patients Develop Psoriatic Arthritis?

Authors:  Kristine Busse; Wilson Liao
Journal:  Psoriasis Forum       Date:  2010

3.  Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls.

Authors:  Nádia Couto Bavoso; Jackson Machado Pinto; Maria Marta Sarquis Soares; Michelle Dos Santos Diniz; Antônio Lúcio Teixeira Júnior
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.